Literature DB >> 15705073

Incidence of adrenal involvement and assessing adrenal function in patients with renal cell carcinoma: is ipsilateral adrenalectomy indispensable during radical nephrectomy?

Hiroshi Yokoyama1, Masatoshi Tanaka.   

Abstract

OBJECTIVE: To determine the value of ipsilateral adrenalectomy with radical nephrectomy, by investigating the clinical aspects of adrenal involvement and adrenocortical function in patients with renal cell carcinoma (RCC). PATIENTS AND METHODS: The demographic, clinical and pathological data of adrenal involvement were reviewed in 247 patients with RCC. To evaluate adrenocortical function, 14 patients (adrenalectomy in eight, adrenal-sparing in six) had a rapid adrenocorticotropic hormone (ACTH) stimulation test before and 2 weeks after surgery.
RESULTS: There was adrenal involvement with RCC in seven of the 247 (2.8%) patients (a solitary adrenal metastatic tumour in four and direct extension into the adrenal gland in three). All adrenal involvement was detectable on abdominal computed tomography before surgery, and these patients had a large primary renal tumour of > pT2 and/or distant metastasis. Plasma cortisol levels declined significantly more in response to the rapid ACTH stimulation test in those treated by adrenalectomy than in those with spared adrenal glands at 2 weeks after surgery (P < 0.05), while there was no significant difference between the groups before surgery.
CONCLUSIONS: These results suggest that unconditional ipsilateral adrenalectomy with radical nephrectomy for RCC should be avoidable, and thus preserve the reserve of adrenocortical function, as preoperative imaging, especially thin-slice multidetector helical computed tomography, can detect adrenal involvement with RCC in most cases. Unilateral adrenalectomy might cause an irreversible impairment of the reserve of adrenocortical function.

Entities:  

Mesh:

Year:  2005        PMID: 15705073     DOI: 10.1111/j.1464-410X.2005.05332.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  9 in total

1.  Comparative effectiveness of adrenal sparing radical nephrectomy and non-adrenal sparing radical nephrectomy in clear cell renal cell carcinoma: Observational study of survival outcomes.

Authors:  Gregory J Nason; Leon G Walsh; Ciaran E Redmond; Niall P Kelly; Barry B McGuire; Vidit Sharma; Michael E Kelly; David J Galvin; David W Mulvin; Gerald M Lennon; David M Quinlan; Hugh D Flood; Subhasis K Giri
Journal:  Can Urol Assoc J       Date:  2015-09-09       Impact factor: 1.862

2.  Predictive Ability of Preoperative CT Scan in Determining Whether the Adrenal Gland is Spared at Radical Nephrectomy.

Authors:  Gregory J Nason; Asadullah Aslam; Subhasis K Giri
Journal:  Curr Urol       Date:  2016-09-20

3.  Abnormalities in incidentally removed adrenal glands.

Authors:  H Buurman; W Saeger
Journal:  Endocr Pathol       Date:  2006       Impact factor: 3.943

4.  Hyponatremia as a prognostic and predictive factor in metastatic renal cell carcinoma.

Authors:  A N Jeppesen; H K Jensen; F Donskov; N Marcussen; H von der Maase
Journal:  Br J Cancer       Date:  2010-02-09       Impact factor: 7.640

5.  Renal Cell Carcinoma with Simultaneous Bilateral Adrenal Metastasis: Ipsilateral Radical Nephrectomy with Contralateral Adrenal Preservation.

Authors:  Mohammad Kazem Moslemi; Hossein Saghafi; Mohammad Hasan Dehghani Firoozabadi
Journal:  Case Rep Oncol       Date:  2010-10-19

6.  [Coagulopathy resulting from lupus anticoagulant antibodies as a paraneoplastic phenomenon in renal cell carcinoma relapse].

Authors:  N Berdjis; M Meier; F Hoeppner; H Behrendt
Journal:  Urologe A       Date:  2008-01       Impact factor: 0.639

7.  Hyponatremia as a powerful prognostic predictor for Japanese patients with clear cell renal cell carcinoma treated with a tyrosine kinase inhibitor.

Authors:  Junya Furukawa; Hideaki Miyake; Yuji Kusuda; Masato Fujisawa
Journal:  Int J Clin Oncol       Date:  2014-06-04       Impact factor: 3.402

8.  Prognostic value of normal sodium levels in patients with metastatic renal cell carcinoma receiving tyrosine kinase inhibitors.

Authors:  Giandomenico Roviello; Martina Catalano; Ugo De Giorgi; Marco Maruzzo; Sebastiano Buti; Elisabetta Gambale; Giuseppe Procopio; Carlotta Ottanelli; Enrico Caliman; Luca Isella; Pierangela Sepe; Nicole Brighi; Matteo Santoni; Luca Galli; Raffaele Conca; Laura Doni; Lorenzo Antonuzzo
Journal:  Front Oncol       Date:  2022-08-16       Impact factor: 5.738

9.  Chronic primary adrenal insufficiency after unilateral adrenonephrectomy: A case report.

Authors:  Satoshi Yoshiji; Kimitaka Shibue; Toshihito Fujii; Takeshi Usui; Keisho Hirota; Daisuke Taura; Mayumi Inoue; Masakatsu Sone; Akihiro Yasoda; Nobuya Inagaki
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.